跳转至内容
Merck
CN

MAB5320

Anti-α-Synuclein (SNCA) Antibody

CHEMICON®, mouse monoclonal, 7B12.2

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

抗突触核蛋白α抗体(克隆7B12.2), culture supernatant, clone 7B12.2, Chemicon®

biological source

mouse

antibody form

culture supernatant

antibody product type

primary antibodies

clone

7B12.2, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunohistochemistry: suitable
western blot: suitable

isotype

IgG

NCBI accession no.

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

Quality Level

Gene Information

human ... SNCA(6622)

Analysis Note

对照
脑组织

Application

以α-突触核蛋白进行的蛋白质印迹:1:2,000-1:4,000。

泳道1:重组人α-突触核蛋白

泳道2:重组人β-突触核蛋白

泳道3:重组人γ-突触核蛋白

免疫组化(冷冻切片):1:250-1:500

最佳工作稀释度必须由最终用户进行确定。
抗突触核蛋白抗体(α,克隆7B12.2)可检测突触核蛋白的水平 & 已有相关文献发表&经过验证可用于IH & WB。
研究子类别
神经退行性疾病
研究类别
神经科学

Biochem/physiol Actions

与α-突触核蛋白反应。蛋白质印迹法显示该抗体不与β-或γ-突触核蛋白反应。研究显示该抗体可以使帕金森病患者脑冷冻切片的路易体以及多系统萎缩患者脑冷冻切片中的神经胶质包涵体( glial inclusion)染色。

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

General description

15-18 kDa

Immunogen

重组人 α-突触核蛋白。

Other Notes

替代:04-1053
浓度:请参考批次特异性浓缩物的检验报告。

Physical form

未纯化
来自灌注系统的未纯化组织培养物上清液,在装入小瓶之前通过0.2μ微米膜过滤。产品包含20%FBS和环丙沙星,终浓度为10μg/mL。

Preparation Note

自收到之日起在-20°C可稳定保存1年。避免反复冻融。为了最大程度地回收产品,在融化后和取下盖子之前,将原始小瓶进行离心。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Francesca Sardone et al.
Matrix biology : journal of the International Society for Matrix Biology, 55, 90-105 (2016-10-19)
In response to injury, tendon fibroblasts are activated, migrate to the wound, and contribute to tissue repair by producing and organizing the extracellular matrix. Collagen VI is a microfibrillar collagen enriched in the pericellular matrix of tendon fibroblasts with a
Nanoscale imaging of individual amyloid aggregates extracted from brains of Alzheimer and Parkinson patients reveals presence of lipids in I?-synuclein but not in amyloid I?1-42 fibrils.
Zhaliazka, et al.
Protein Science, 32, e4598-e4598 (2023)
Xichen Zheng et al.
The Journal of clinical investigation, 128(5), 2104-2115 (2018-04-18)
Immune checkpoint blockade (ICB) has demonstrated curative potential in several types of cancer, but only for a small number of patients. Thus, the identification of reliable and noninvasive biomarkers for predicting ICB responsiveness is an urgent unmet need. Here, we
Francesca Sardone et al.
Journal of cellular physiology, 229(7), 878-886 (2013-12-21)
Cell-extracellular matrix interaction plays a major role in maintaining the structural integrity of connective tissues and sensing changes in the biomechanical environment of cells. Collagen VI is a widely expressed non-fibrillar collagen, which regulates tissues homeostasis. The objective of the
Patricia A Trimmer et al.
Journal of neurochemistry, 88(4), 800-812 (2004-02-06)
Many models of Parkinson's disease (PD) have succeeded in replicating dopaminergic neuron loss or alpha-synuclein aggregation but not the formation of classical Lewy bodies, the pathological hallmark of PD. Our cybrid model of sporadic PD was created by introducing the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持